.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Find suppliers and generic API sources
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Accenture
Citi
Farmers Insurance
Novartis
QuintilesIMS
Federal Trade Commission
Fish and Richardson
Johnson and Johnson
Argus Health
AstraZeneca

Generated: July 24, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 040226

« Back to Dashboard
NDA 040226 describes PERPHENAZINE, which is a drug marketed by Ani Pharms Inc, Vintage Pharms, Pharm Assoc, Wilshire Pharms Inc, Watson Labs Inc, Sandoz, Mylan Pharms Inc, Watson Labs, Par Pharm, Ivax Sub Teva Pharms, Mylan, and Sun Pharm Inds, and is included in forty-five NDAs. It is available from eleven suppliers. Additional details are available on the PERPHENAZINE profile page.

The generic ingredient in PERPHENAZINE is amitriptyline hydrochloride; perphenazine. There are thirteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the amitriptyline hydrochloride; perphenazine profile page.

Summary for NDA: 040226

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Antiemetics
Antipsychotics
Formulation / Manufacturing:see details

Pharmacology for NDA: 040226

Ingredient-typePhenothiazines

Suppliers and Packaging for NDA: 040226

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
PERPHENAZINE
perphenazine
TABLET;ORAL 040226 ANDA Par Pharmaceutical 0603-5060 0603-5060-21 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0603-5060-21)
PERPHENAZINE
perphenazine
TABLET;ORAL 040226 ANDA Par Pharmaceutical 0603-5060 0603-5060-28 500 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0603-5060-28)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength2MG
Approval Date:Dec 31, 1998TE:ABRLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength4MG
Approval Date:Dec 31, 1998TE:ABRLD:No

Summary for product number 003

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength8MG
Approval Date:Dec 31, 1998TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Dow
Cantor Fitzgerald
Chubb
US Army
Fish and Richardson
Federal Trade Commission
Julphar
Express Scripts
UBS
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot